Home > Cashflow Statement > BETA DRUGS

BETA DRUGS
Cashflow Statement

BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹54 Cr₹62 Cr₹49 Cr₹41 Cr₹34 Cr
Adjustment ₹9.88 Cr₹-6.37 Cr₹-4.25 Cr₹2.02 Cr₹5.10 Cr
Changes In working Capital ₹-27 Cr₹-19 Cr₹-14 Cr₹-20 Cr₹-9.77 Cr
Cash Flow after changes in Working Capital ₹37 Cr₹36 Cr₹31 Cr₹23 Cr₹30 Cr
Cash Flow from Operating Activities ₹37 Cr₹36 Cr₹31 Cr₹23 Cr₹30 Cr
Cash Flow from Investing Activities ₹-51 Cr₹-36 Cr₹-14 Cr₹-19 Cr₹-22 Cr
Cash Flow from Financing Activities ₹-8.07 Cr₹118 Cr₹-7.49 Cr₹-2.47 Cr₹-0.97 Cr
Net Cash Inflow / Outflow ₹-22 Cr₹118 Cr₹9.47 Cr₹1.84 Cr₹6.90 Cr
Opening Cash & Cash Equivalents ₹147 Cr₹29 Cr₹19 Cr₹17 Cr₹10 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹125 Cr₹147 Cr₹29 Cr₹19 Cr₹17 Cr

Compare Cashflow Statement of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹1,958.3 Cr -2.9% 6% 8.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,228.0 Cr 1.2% 9.1% 6.6% Stock Analytics
DIVIS LABORATORIES ₹296,741.0 Cr -2.7% 22.2% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,413.0 Cr -1% 2% 20.8% Stock Analytics
DR REDDYS LABORATORIES ₹116,771.0 Cr 1.5% 13% 12.1% Stock Analytics
CIPLA ₹114,397.0 Cr 1.7% 7.8% -7.3% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-2.9%

6%

8.2%

SENSEX

1.4%

12.4%

-1.7%


You may also like the below Video Courses